Peer-review started: June 1, 2018
First decision: June 5, 2018
Revised: June 28, 2018
Accepted: June 30, 2018
Article in press: June 30, 2018
Published online: August 7, 2018
Processing time: 67 Days and 17.7 Hours
The incidence of the collapsing variant of focal segmental glomerulosclerosis (FSGS) as a human immunodeficiency virus (HIV)-associated nephropathy has reduced since the introduction of antiretroviral therapy (ART). However, the incidence of other variants of FSGS, except for the collapsing variant, is increasing, and its therapeutic strategies remain uncertain. A 60-year-old HIV infected man in remission with ART was admitted for progressive renal insufficiency and nephrotic-ranged proteinuria. Renal biopsy revealed a tip variant of FSGS and his clinical manifestations resolved with corticosteroid therapy. HIV infected patients might develop non-collapsing FSGS, including tip variant of FSGS and corticosteroid therapy might be effective for them. A renal biopsy might be essential to determine the renal histology and to decide on corticosteroid therapy.
Core tip: Collapsing variant of focal segmental glomerulosclerosis (FSGS) is the most common kidney disease in human immunodeficiency virus (HIV) infected patients. However, the incidence has reduced since the introduction of antiretroviral therapy (ART). Although the incidence of other variants of FSGS, except for the collapsing variant, is increasing, the tip variant of FSGS has been rarely reported. Therefore, we report an HIV infected patient under remission with ART, who presented with a rare tip variant of FSGS, which resolved with corticosteroid therapy. We suggest a renal biopsy might be essential to determine the renal histology and to decide on corticosteroid therapy.
